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Arabidopsis (ACCESSION ACO07591) METLFRVSLRLLPVSAAVTCRSIRFPVSRPGSSHLLNRKLYNLPTSSSSS 50 
-* *- - 1* 
E coli (ACCESSION AEOOO407 U0OO96) ————————————————————————————————— --KVAKPVEEVNAEIQR 30 
Arabidopsis (ACCESSION ACO07591) LSTKAGWLLGLGEKKKKVDLPEIVASGDPVLHEKAREVDPGEIGSERIQK lOO 
- ~k * ink 
E coli (ACCESSION AEOOO407 UOOO96) IVDDME‘E'I‘MYAEEGIGLAATQVDIHQRIIVIDVSENRD ---------- -- 68 
Arabidopsis (ACCESSION ACOO7591) IIDDMIKW/IRLAPGVGLAAPQIGVPLRIIVLEDTKEYISYAPKEEILAQE 150 
*:**-k: : _* *:****_*: _ z ++**: ; z z : 
E coli (ACCESSION AEOOO407 U00096) ---"ERLVLINPELLEKSGE-TGIEEGCLSIPEQRALVPRAEKVKIRALD 113 
Arabidopsis (ACCESSION ACOO7591) RRHFDLMV'MV'NPVLKERSNKKALFE'EGCLSVDGFRAAVERYLEVVVIGYD 200 
- .*. .** * *.1( . . . *****- ** * * -* - 4. 
E coli (ACCESSION AEOOO407 UOOO96) RDGKPFELEADGLLAICIQHEMDHLVGKLFMDYLSPLKQQRIRQKVEKLD 163 
Arabidopsis (ACCESSION ACOO7591) RQGKRIEVNASGWQARILQHECDHLDGNLYVDIQ/IVPRTFRTVDNLDLPLA 250 
‘A’ z ** :*= :47‘?! * :*** *** ivz‘l'z :* : * I : : z i 
E coli (ACCESSION AE000407 UOOO96) RLKARA——— 169 
Arabidopsis (ACCESSION ACOO7591) EGCPKLGPQ 259 
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INHIBITORS OF PLANT PEPTIDE 
DEFORMYLASE FOR USE AS BROAD 
SPECTRUM HERBICIDES AND METHOD 
FOR IDENTIFYING THE SAME 
FIELD OF THE INVENTION 
The invention relates to a method of identifying herbi 
cides and to the use of inhibitors of plant peptide deformy 
lase as broad spectrum herbicides. 
BACKGROUND 
Ribosome-mediated synthesis of proteins begins With a 
methionine residue. In prokaryotes and eukaryotic 
organelles (mitochondria and chloroplasts), the methionyl 
moiety carried by the initiator tRNA is N-formylated prior to 
its incorporation into a polypeptide (Meinnel and Blanquet, 
J. Bacteriol. 175:7737—7740 (1993)). N-formylmethionine 
is therefore alWays incorporated at the N-terminus of a 
nascent polypeptide in prokaryotes (Adams, J. M. and 
Capecchi, M., Proc. Natl. Aca. Sci. USA. 55:147—155 
(1966); Webster et al., Proc. Natl. Acad. Sci. USA. 
55 :155—161 (1966)). HoWever, most mature proteins do not 
retain the N-formyl group (Marcker, K. and Sanger, F. J. 
Mol. Biol. 8:835—840 (1964)). Instead, the 
N-formylmethionine group is removed post- or 
co-translationally in a process knoWn as deformylation, 
Which is catalyZed by peptide deformylase. 
Deformylation is catalyZed by peptide deformylase Which 
cleaves the formyl group from the nascent polypeptide chain 
(Adams, J., J. Mol. Biol. 33:571—589 (1968); Livingston, D. 
M. and Leder, P., Biochemistry 8:435—443 (1969); Takeda, 
M. and Webster, R. B, Proc. Natl. Acad. Sci. USA. 
60:1487—1494 (1968)). 
Prior to the present invention, research in the area of 
peptide deformylase activity and enZymology focused on the 
bacterial enZyme. For example, the structure of the core 
domain of E. coli peptide deformylase Was solved by NMR 
(Meinnel, T. et al., J. Mol. Biol. 262:375—386 (1996)) and 
the structure of the full-length protein by X-ray crystallog 
raphy (Chan et al., Biochemistry 36:13904—13909 (1997)). 
Becker et al., J. Biol. Chemistry 273(19): 11413—11416 
(1998) solved the structure of the catalytically active E. coli 
enZyme in the nickel-bound form (PDF-Ni) and in inhibitor 
complexed form. 
More recently, Ragusa et al., J. Mol. Biol. 289: 
1445—1457 (1999), investigated the substrate speci?city of 
Escherichia coli peptide deformylase by measuring the 
ef?ciency of the enZyme to cleave formylpeptides. Durand et 
al., Archives Biochemistry and Biophysics, 367(2):297—302 
(1999), tested a variety of peptide aldehydes and identi?ed 
calpeptin as a potent inhibitor of E. coli and B. subtilis 
peptide deformylase. 
The overall focus in the ?eld has been engineering 
site-speci?c inhibitors of peptide deformylase With a goal of 
developing broad-spectrum antibiotics With loW to no mam 
malian toxicity. Rajagopalan et al., Biochemistry 
36:13910—13918 (1997), identi?ed speci?c and potent 
inhibitors of the bacterial enZyme Which are potentially 
novel and neW antibiotic agents. Meinnel et al., Biochem 
istry 38:4287—4295 (1999) designed and synthesiZed sub 
strate analogue inhibitors of bacterial peptide deformylase 
and studied their capacity to undergo hydrolysis. To aid in 
the design of both the cobalt and Zinc containing E. coli 
peptide deformylase, Hao et al., Biochemistry 
38:4712—4719 (1999), studied the structure of the protein 
inhibitor complexes of the cobalt and Zinc containing E. coli 
enzyme. 
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Prior to the present invention, it Was generally accepted 
that peptide deformylase genes and proteins Were absent 
from eukaryotic cells. The present invention unexpectedly 
establishes, for the ?rst time, the existence of a peptide 
deformylase gene and protein in eukaryotic cells, particu 
larly in plant cells. The inventors have found that the 
deformylase is a novel and suitable target for identifying 
neW broad spectrum herbicides. 
SUMMARY OF THE INVENTION 
In a ?rst aspect, the present invention relates to a plant 
peptide deformylase gene Which is expressed in a higher 
plant. A particularly preferred higher plant is Arabidopsis. 
More particularly preferred is the strain Arabidopsis 
thaliana. 
In additional aspects, the present invention relates to a 
nucleotide and amino acid sequence encoding a plant pep 
tide deformylase. 
In another aspect, the present invention relates to a 
recombinant vector comprising the peptide deformylase 
nucleotide sequence described above. 
In another aspect, the invention relates to a host cell that 
is transformed or transfected With the recombinant vector of 
the invention. The host cell may be a prokaryotic cell, such 
as a bacterial cell, or a eukaryotic cell, such as a plant cell 
or a mammalian cell. 
In yet another aspect, the present invention relates to an 
isolated or recombinantly expressed peptide deformylase 
polypeptide Which is encoded by a plant peptide deformy 
lase gene as described above. 
In still another aspect, the present invention relates to a 
method for introducing the plant peptide deformylase gene 
into a cell Which does not express said gene, Which method 
comprises transforming a higher plant seed crop With the 
recombinant vector (vector containing a peptide deformy 
lase gene) such that the cell expresses the peptide deformy 
lase enZyme encoded by the gene. The cell may be a 
prokaryotic cell or a eukaryotic cell. 
In another aspect, the present invention provides a method 
of identifying an inhibitor of plant peptide deformylase, said 
method comprising: 
(a) incubating a catalytically effective amount of a plant 
peptide deformylase, With a suitable substrate, in the 
presence or absence of a candidate inhibitor compound, 
and 
(b) detecting and quantifying the enZyme product formed. 
The method may further comprises comparing the amount 
of enZyme product formed in the presence and absence of 
said candidate inhibitor. 
In a preferred embodiment, the method of the invention 
permits identi?cation of inhibitors of peptide deformylase 
derived from Arabidopsis thaliana. 
The invention also provides a method of identifying 
herbicides Which comprises testing a compound in a peptide 
deformylase inhibition assay, and Where a measurable 
reduction of plant peptide deformylase is observed, subject 
ing the compound to an in vivo test for herbicidal activity. 
In another aspect, the invention relates to herbicides 
Which act by inhibiting plant peptide deformylase and Which 
are identi?ed by the methods of the invention. 
In another aspect, the invention provides a method of 
combating Weeds comprising treating said Weeds With a 
herbicide, Wherein said herbicide is a compound Which is an 
inhibitor of peptide deformylase. A preferred herbicide is 
actinonin, Which is a potent inhibitor of plant peptide 
deformylase. 
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The invention also provides a method of controlling 
vegetation comprising applying to plant foliage a herbicid 
ally effective amount of an inhibitor of peptide deformylase. 
In a further aspect, the invention provides a method of 
inhibiting the activity of plant peptide deformylase compris 
ing exposing said peptide deformylase to an effective 
amount of an inhibitor of said peptide deformylase. 
Still further, the invention provides an antibody directed 
against peptide deformylase isolated from Arabidopsis 
thaliana. The antibody may be a polyclonal or a monoclonal 
antibody. 
In an additional aspect, the invention also provides a 
transgenic plant, Wherein said transgenic plant is engineered 
to be resistant to an inhibitor of plant peptide deformylase. 
In a further aspect, the invention provides a herbicidal 
composition comprising an inhibitor of plant peptide 
deformylase. In accordance With the present invention, the 
inhibitor is a herbicide, i.e. a compound having herbicidal 
activity. The composition of the invention may also contain 
a herbicidally acceptable surfactant. 
In yet another aspect, the present invention provides a 
method of controlling vegetation comprising applying to 
plant foliage a herbicidal composition, Wherein said herbi 
cidal composition comprises an inhibitor of plant peptide 
deformylase. Those of skill in the art Would recogniZe that 
the herbicide actinonin may be included in compositions of 
the present invention. 
Additional aspects of the invention Will be described 
throughout the speci?cation. 
BRIEF DESCRIPTION OF THE FIGURES 
The ?le of this patent contains at least one draWing 
executed in color. Copies of this patent With color draWings 
Will be provided by the Patent and Trademark Of?ce upon 
request and payment of the necessary fee. 
FIG. 1A shoWs a CLUSTAL W (1.8) alignment of Ara 
bidopsis (truncated to the ChloroP predicted transit peptide) 
(SEQ ID NO.: 7) and E. coli peptide deformylase proteins 
(SEQ ID NO.: 8). 
FIG. 1B shoWs a CLUSTAL W (1.8) alignment of Ara 
bidopsis (truncated to the ChloroP predicted transit peptide) 
(SEQ ID NO.: 9) and Chlamydia peptide deformylase pro 
teins (SEQ ID NO.: 10). All three conserved proteins motifs 
found in prokaryotic sequences are present in the Arabidop 
sis peptide deformylase (AtDEF1). 
FIG. 2 is a gel shoWing an amplicon of the expected siZe, 
630 bp, Which Was created When Arabidopsis RNA Was 
reversed-transcribed and Atdef1 ampli?ed With gene spe 
ci?c primers (RLH 146x147). 
FIG. 3 shoWs the results of in vitro import ofArabia'opsis 
thaliana deformylase (AtDEF1) protein into isolated pea 
chloroplasts under standard, in vitro import conditions and 
processing to a mature form once inside the plastid. The 5.5 
kD shift from predicted precursor (28.9 kD) to processed 
(23.4 kD) forms Was observed after 15 and 30 minutes after 
initiation of the assay. Only the processed protein Was 
present after thermolysin treatment of the chloroplasts after 
30 minutes of import. 
FIG. 4 shoWs detection of an expected siZe protein from 
~100 pg Arabidopsis total protein extract (soluble, lane 2; 
insoluble, lane 3) by AtDEF1 antibody (Rabbit 95728) at 
150,000. Inclusion bodies (50 ng) used as antigen in making 
the antibody Were included in the standard lane (lane 1). 
FIG. 5 shoWs ten-day old pea plants 48 hours after 
application of actinonin (2.5 mg/ml) in 0.1% TWeen-20 (left) 
or treated With 0.1% TWeen-20 alone (right). 
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FIG. 6 is a 1% agarose gel in TBE buffer containing 0.1 
pig/ml ethidium bromide and subjected to electrophoresis. 
Amplicons of Reverse Transcriptase-Polymerase Chain 
Reactions (RT-PCR) reactions of Atdef2 are depicted. 
FIG. 7 is a 15% SDS-PAGE shoWing AtDEF2 after 
puri?cation. 
FIG. 8 shoWs spectrophotometric detection and quantita 
tion of p-nitroaniline released from formyl-Met-Leu-p 
nitroanilide substrate folloWing sequential action of AtDEF2 
and Aeromonas proteolytica aminopeptidase. 
DETAILED DESCRIPTION OF THE 
INVENTION 
As discussed above, the present inventors have found that 
plant cells contain a peptide deformylase gene and protein, 
and the deformylase provides a novel and suitable target for 
identifying neW broad spectrum herbicides. The identi?ca 
tion of this neW target has Widespread implications in the 
agricultural area. Methods of identifying inhibitors of this 
target Will be useful for identifying neW broad spectrum 
herbicides, Which Will be used to control the groWth of 
Weeds. Chemical Weed control using herbicides is a poW 
erful tool in the modern technological age. In fact, it has 
become almost a universal practice to use herbicides to 
control groWth of undesirable vegetation such as Weeds or 
plants. 
A particularly useful type of herbicide is one having a 
broad spectrum of herbicidal activity. The use of broad 
spectrum herbicides offers the advantage of obviating the 
need for multiple herbicides. Since some Weeds are resistant 
to herbicides, clearly there is a need for the identi?cation of 
neW targets of inhibition and for identi?cation and produc 
tion of effective herbicides that inhibit such targets. 
The present invention is based, at least in part, on the 
discovery of a plant nuclear gene that encodes a chloroplast 
targeted peptide deformylase polypeptide. UtiliZing 
sequence data obtained from the Arabidopsis genome 
sequencing project (Accession Number AC 007591), the 
present inventors have isolated a cDNA from Arabidopsis 
thaliana that encodes peptide deformylase. The gene has 
substantial homology to bacterial peptide deformylase. The 
deduced translation of this DNA sequence revealed the 
presence of all three conserved protein motifs associated 
With prokaryotic peptide deformylase. (See FIG. 1B for 
sequence alignment.) 
Thus, the present invention provides a plant peptide 
deformylase gene Which is expressed in higher plants. A 
particularly preferred higher plant is Arabidopsis. More 
particularly preferred is the strain Arabidopsis thaliana. 
The invention also provides polynucleotide sequences 
Which encode a plant peptide deformylase. In particular, the 
invention encompasses the polynucleotide sequences of 
Atdef1 and Atdef2 genes. Also Within the scope of the 
invention are polynucleotide sequences encoding a plant 
peptide deformylase Which have substantial identity to the 
polynucleotide sequence of Atdef1 or Atdef2. Such poly 
nucleotide sequences are readily identi?able by those skilled 
in the art using techniques knoWn in the art such as site 
speci?c mutagenesis and hybridiZation technology, such as 
hybridiZation under stringent conditions. 
The invention further provides an isolated and puri?ed 
polynucleotide sequence Which hybridiZes under stringent 
conditions to the polynucleotide encoding the polypeptide 
comprising the amino acid sequence of AtDEF1 or AtDEF2 
or a fragment thereof, as Well as an isolated and puri?ed 
polynucleotide Which is complementary to the polynucle 
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otide encoding the polypeptide comprising the amino acid 
sequence of AtDEFl or AtDEF2 or a fragment thereof. 
The invention also provides an isolated and puri?ed 
polynucleotide sequence comprising the polynucleotide 
sequence of Atdefl or a fragment thereof, and an isolated 
and puri?ed polynucleotide variant having at least 70% 
polynucleotide sequence identity to the polynucleotide com 
prising the polynucleotide sequence of Atdefl or Atdef2 or 
a fragment thereof. The invention also provides an isolated 
and puri?ed polynucleotide having a sequence complemen 
tary to the polynucleotide comprising the polynucleotide 
sequence of Atdefl or Atdef2 or a fragment thereof. 
Amino acid sequences encoding a plant peptide deformy 
lase are also Within the purvieW of the present invention. 
Such amino acids sequences include but are not limited to 
the amino acid sequences of AtDEFl and AtDEF2. 
Additionally, and of equal importance, the inventors have 
identi?ed a putative N-terminal targeting sequence for chlo 
roplasts. (FIGS. 1a and 1b) Thus, perhaps as a remnant of its 
prokaryotic origins, the chloroplast has retained N-formyl 
methionine as its initiator of protein translation. 
The present invention is based on a novel herbicidal mode 
of action, i.e., inhibition of plant peptide deformylase. 
Discovery of this novel mode of action opens up the 
opportunity for identifying novel chemicals that inhibit the 
enZyme target either directly or folloWing metabolism to an 
active inhibitor in plants (“indirect inhibitors”). 
Because all non-parasitic plants contain chloroplasts, and 
deletion and/or mutation of peptide deformylase in prokary 
otic organisms is lethal, it is expected that inhibition of 
peptide deformylase activity in the chloroplast Will be lethal 
to plants. 
Thus, the invention relates to the identi?cation of 
compounds, as Well as the development of neW compounds 
capable of acting as highly speci?c inhibitors of chloroplas 
tic peptide deformylase, for use as broad spectrum herbi 
cides. 
The invention provides a method of identifying potential 
herbicides Which comprises testing a candidate in a peptide 
deformylase assay for direct and indirect inhibitors. Indirect 
inhibitors are those inhibitors that require conversion in 
plants. 
More speci?cally, the invention relates to a method of 
identifying an inhibitor of plant peptide deformylase, said 
method comprising: 
(a) incubating an effective amount of a plant peptide 
deformylase, With a suitable substrate, in the presence 
or absence of a candidate inhibitor compound; and 
(b) detecting and quantifying the enZyme product formed. 
The method may further comprise comparing the amount 
of enZyme product formed in the presence and absence of 
said candidate inhibitor. 
The invention permits identi?cation of inhibitors of pep 
tide deformylase derived from Arabidopsis thaliana as Well 
as inhibitors of peptide deformylase derived from other 
plants including, but not limited to, soybean, sun?oWer, 
cotton, corn, tobacco, alfalfa, Wheat, barley, oats, sorghum, 
hardWood and softWood trees, forage grasses, pea, canola, 
?ax, tomato, sugar beet, potato, rice, lettuce and radish. 
The invention employs an isolated or recombinantly 
expressed plant peptide deformylase polypeptide encoded 
by a plant peptide deformylase gene. The invention also 
encompasses variants of this polypeptide, and particularly 
those Which retain peptide deformylase activity. 
AcDNA for a peptide deformylase, such as an Arabidop 
sis peptide deformylase cDNA, may be engineered and 
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inserted into bacterial expression vectors to verify functional 
activity, subcellular localiZation, and to generate a suitable 
amount of the protein for crystalliZation attempts and acqui 
sition of antibodies. 
Production of a recombinant plant peptide deformylase 
polypeptide may be achieved by a method comprising: 
(a) transforming a suitable host cell With a vector com 
prising a gene encoding a plant peptide deformylase 
polypeptide, the gene being operably linked to suitable 
regulatory sequences; 
(b) groWing the transformed cell under conditions Where 
the peptide deformylase is expressed. 
To obtain a peptide deformylase polypeptide, recombi 
nant host cells expressing the peptide deformylase polypep 
tide may be groWn in a conventional manner in a suitable 
culture medium and then lysed using conventional means 
such as enZymatic degradation or detergents or the like. The 
expressed protein may be isolated as an insoluble inclusion 
body. Alternatively, the protein can be separated and puri?ed 
by standard chromatography techniques. 
Transformation of a nucleic acid molecule into a cell can 
be accomplished by any method by Which a nucleic acid 
molecule can be inserted into the cell. Transformation tech 
niques include, but are not limited to, transfection, 
electroporation, microinjection, lipofection, adsorption, and 
protoplast fusion. 
Suitable host cells are knoWn to those of skill in the art 
and include, but are not limited to bacterial cells such as 
BL21(DE3)pLysS, BL21(DE3), and G1724. Those of skill 
in the art Would recogniZe that the host cell encompassed by 
the present invention may be a prokaryotic cell, such as a 
bacterial cell, or a eukaryotic cell, such as a plant cell or a 
mammalian cell. 
Suitable expression vectors are knoWn and routinely used 
in the art and may include, but are not limited to, pLEX and 
pET. 
One type of recombinant vector, referred to herein as a 
recombinant molecule, comprises a nucleic acid molecule of 
the present invention operatively linked to an expression 
vector. The phrase operatively linked refers to insertion of a 
nucleic acid molecule into an expression vector in a manner 
such that the molecule is able to be expressed When trans 
formed into a host cell. As used herein, an expression vector 
is a DNA or RNA vector that is capable of transforming a 
host cell and of effecting expression of a speci?ed nucleic 
acid molecule. Preferably, the expression vector is also 
capable of replicating Within the host cell. Expression vec 
tors can be either prokaryotic or eukaryotic, and are typically 
viruses or plasmids. Expression vectors of the present inven 
tion include any vectors that function (i.e., direct gene 
expression) in recombinant cells of the present invention, 
including in bacterial, fungal, endoparasite, insect, other 
animal, and plant cells. Preferred expression vectors of the 
present invention can direct gene expression in bacterial, 
yeast, insect and mammalian cells and more preferably in 
the cell types disclosed herein. 
In particular, expression vectors of the present invention 
contain regulatory sequences such as transcription control 
sequences, translation control sequences, origins of 
replication, and other regulatory sequences that are compat 
ible With the recombinant cell and that control the expres 
sion of nucleic acid molecules of the present invention. In 
particular, recombinant molecules of the present invention 
include transcription control sequences. Transcription con 
trol sequences are sequences Which control the initiation, 
elongation, and termination of transcription. Particularly 
important transcription control sequences are those Which 
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control transcription initiation, such as promoter, enhancer, 
operator and repressor sequences. Suitable transcription 
control sequences include any transcription control 
sequence that can function in at least one of the recombinant 
cells of the present invention. Avariety of such transcription 
control sequences are knoWn to those skilled in the art. 
Preferred transcription control sequences include those 
Which function in bacterial, yeast, insect and mammalian 
cells, such as, tac, lac, trp, trc, oXy-pro, omp/lpp, rrnB, 
bacteriophage lambda (such as lambda PL and lambda PR 
and fusions that include such promoters), bacteriophage T7, 
T7lac, bacteriophage T3, bacteriophage SP6, bacteriophage 
SP01, metallothionein, alpha-mating factor, Pichia alcohol 
oXidase, alphavirus subgenomic promoters (such as Sindbis 
virus subgenomic promoters), antibiotic resistance gene, 
baculovirus, Heliothis Zea insect virus, vaccinia virus, 
herpesvirus, raccoon poXvirus, other poXvirus, adenovirus, 
cytomegalovirus (such as intermediate early promoters), 
simian virus 40, retrovirus, actin, retroviral long terminal 
repeat, Rous sarcoma virus, heat shock, phosphate and 
nitrate transcription control sequences as Well as other 
sequences capable of controlling gene expression in 
prokaryotic or eukaryotic cells. Additional suitable tran 
scription control sequences include tissue-speci?c promot 
ers and enhancers as Well as lymphokine-inducible promot 
ers (e. g., promoters inducible by interferons or interleukins). 
Puri?ed peptide deformylase is highly active toWard 
N-formylated peptide substrates, thus rendering these pep 
tides suitable for use in the methods of the present invention. 
Suitable substrates include, but are not limited to formylated 
dipeptides and formyl-Met-Leu-p-nitroanilide as described 
by Wei and Pei, Analytical Biochemistry 250:29—34 (1997) 
and other formylated peptides as described by Rajagopalan 
et al., Biochemistry 36:13910—13918 (1997). 
Peptide deformylase activity may be assessed by detect 
ing and quantifying the amount of enZyme product formed 
in the method of the invention. Speci?cally, peptide 
deformylase activity can be quanti?ed by measuring the 
amount of released p-nitroaniline (end product) from 
formyl-Met-Leu-p-nitroanilide using a coupled enZyme 
assay With Aeronomonas proteolytica aminopeptidase. This 
permits assessment of the catalytic properties of peptide 
deformylase using a series of synthetic N-formylated pep 
tides as substrates in a continuous spectrophotometric assay. 
(Wei and Pei, Analytical Biochemistry 250:29—34 (1997)). A 
continuous spectrophotometric assay may be used to moni 
tor plant peptide deformylase activity, i.e., to detect and 
quantify the enZyme product formed in the method of the 
invention. Alternatively, a discontinuous spectrophotometric 
assay may also be used. 
The presence of peptide deformylase protein may be 
assessed using immunological methods, such as by using 
antibody directed to the protein or a part thereof, and by 
knoWn enZymatic assays, such as peptide deformylase activ 
ity assays as described above. Coupled deformylase assays 
may also be used for measuring enZymatic activity and 
inhibition thereof as described by Rajagopalan et al., Bio 
chemistry 36:13910—13918 (1997). 
The invention also relates to a method of inhibiting the 
activity of plant peptide deformylase comprising eXposing 
said peptide deformylase to an effective amount of an 
inhibitor of said peptide deformylase. An effective amount 
of an inhibitor is the concentration of the inhibitor that is 
required to reduce plant peptide deformylase activity. 
The invention also relates to a method of identifying 
herbicides Which comprises testing a candidate inhibitor in 
a peptide deformylase assay, and Where a measurable reduc 
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tion of plant peptide deformylase is observed, subjecting the 
candidate inhibitor to conventional test(s) to con?rm the in 
vivo herbicidal activity. 
A measurable reduction includes a reduction that is sta 
tistically signi?cant, statistically signi?cant being de?ned as 
the results from analysis of variance Where the F-ratio, LSD 
(least signi?cant difference), orthogonal/non-orthogonal 
comparison, or any other statistical technique for mean 
separation, that indicates the means are different at 0.05 or 
0.01 level. In one embodiment of the invention, the mea 
surable reduction is at least 10%. 
Conventional tests for con?rming in vivo herbicidal activ 
ity include, but are not limited to, detecting decreases in 
fresh Weight, dry Weight, chlorophyll, protein, and germi 
nation. Typical symptoms resulting from treatment of plant 
foliage With herbicides are cessation of groWth folloWed by 
chlorosis and necrosis. 
Although in vitro peptide deformylase assays Will identify 
intrinsic herbicidal activity, it may in some cases be neces 
sary to use conventional tests to con?rm the in vivo herbi 
cidal activity. Accordingly, the invention further relates to a 
method of identifying potential herbicides that can be 
metaboliZed to an inhibitor of peptide deformylase in plants 
Which comprises testing a compound in a peptide deformy 
lase assay, and Where a measurable reduction of plant 
peptide deformylase is observed, subjecting the compound 
to conventional test(s) to con?rm the in vivo herbicidal 
activity. 
Of course, those skilled in the art Would appreciate that 
the invention encompasses herbicides identi?ed by the 
methods of the invention. The invention also includes the 
use as a herbicide of a compound Which is an inhibitor of 
plant peptide deformylase, With the proviso that the com 
pound is not a general enZyme inhibitor. 
Still further, the invention relates to a method of combat 
ing Weeds comprising treating said Weeds With a herbicide, 
Wherein said herbicide is a compound Which is an inhibitor 
of peptide deformylase in plants. 
The invention also relates to a method of controlling 
vegetation comprising applying to plant foliage a herbicid 
ally effective amount of an inhibitor of peptide deformylase. 
Since bacterial peptide deformylase is a metallo 
hydrolase, compounds containing a metal ion chelating 
group are potential inhibitors of the enZyme. These com 
pounds may also inhibit plant peptide deformylase and are 
encompassed With the scope of the present invention. 
Examples of inhibitors of the invention include, but are 
not limited to, divalent metal chelators, dithiol compounds 
such as 1,2-ethanedithiol, 1,3-propanedithiol, 2,3 
dimercapto-1-propanol, 2,3-dimercapto-1-propanol, 2,3 
dimercapto-1-propanesulfonic acid and 1,5-pentanedithiol. 
Also included are divalent metal-chelating agents such as 
1,10-phenanthroline, 2-mercapto ethanol, glutathione, 
EDTA, thiophenol and thio-speci?c agents [p-(chloro 
mercuri)-benZoate] and iodoacetate. 
Also included are 7,8benZoquinoline, methyl 
2-(sulfanylmethyl) heXanoate (TN) and imino[(5-methoXy 
5-oXo-4-[2-sulfanylmethyl)-heXanoyl] amino pentyl) 
amino] methamine 
The inhibitors of the invention may be substrate analogue 
inhibitors such as thiophan (3-mercapto-2 
benZylpropanoylglycine) and captopril (3-mercapto-2 
methylpropanoyl proline), or other types of enZyme inhibi 
tors knoWn in the art. Such inhibitors may be designed 
and/or synthesiZed using methods knoWn in the art, includ 
ing transition-state-analogue chemistry, such as used by Pei 
et al. (Dept. of Chemistry, The Ohio State University, 
Columbus, Ohio). 
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Also included as inhibitors of the invention are peptide 
aldehydes, including those described by Durand et al., 
Archives Biochemistry and Biophysics, 367(2):297—302 
(1999), as inhibitors of bacterial peptide deformylase. 
Given the absence of a protein crystal structure for plant 
peptide deformylase, Which has a speci?c and unique amino 
acid sequence different from any previously described pep 
tide deformylase, inhibitors of the invention may also 
include novel compounds. 
Those of skill in the art Would recognize that the inhibitors 
of the invention may be used as non-selective herbicides. 
The importance of peptide deformylase to the Well being 
of plants has been demonstrated by the potent herbicidal 
effects obtained When the enZyme is inhibited. Recent stud 
ies have shoWn the fungal product, actinonin, to be an 
inhibitor of bacterial peptide deformylase (Chen et al., 
Biochemistry, 39(6):1256—1263 (2000). A role for peptide 
deformylase in plant groWth Was suggested from analysis of 
the effects of the application of actinonin, on the groWth of 
pea plants. 
As shoWn in FIG. 5 and Example 5, observable alterations 
in plant groWth, i.e., stunting and yellowing of pea plants, 
Were evident in the presence of actinonin. Nearly complete 
inhibition of peptide deformylase activity Was observed in 
an in vitro peptide deformlyase inhibition assay. (FIG. 8 and 
Example 8) This data establishes that the potent herbicidal 
activity of actinonin is due to inhibition of peptide deformy 
lase. This mode of action has not previously been described 
for herbicides. 
Herbicidal Compositions 
The inhibitors of the invention may be formulated as 
herbicidal compositions. A herbicidal composition can be 
formulated in a conventional manner using an inhibitor of 
plant peptide deformylase polypeptide, as an active 
ingredient, together With suitable carriers, diluents, emulsi 
?ers and/or dispersants. The herbicidal composition can be 
formulated as a Wettable poWder, pellets, granules or dust or 
as a liquid formulation With aqueous or non-aqueous sol 
vents as a foam, gel, suspension, or concentrate. 
A method for controlling the groWth of Weeds in accor 
dance With this invention can comprise applying (e.g., 
spraying), to a locus (area) to be protected, an herbicidally 
effective amount of an inhibitor of plant peptide deformylase 
polynucleotide and/or polypeptide of the invention. The 
locus to be protected can include, for example, the habitat of 
the groWing vegetation or an area Where vegetation is to be 
groWn. 
It Will be appreciated that to effect control of undesired 
plant vegetation pursuant to this invention, recourse may be 
had to herbicidal activity Whereby undesired vegetation is 
killed and/or to plant groWth regulant activity Whereby the 
further groWth of the vegetation is stunted, inhibited and/or 
sloWed Without actually killing all of the undesired vegeta 
tion treated With the composition. 
The herbicidal and groWth regulating compositions of the 
invention include aqueous concentrates Which can be 
shipped and stored until diluted With more Water on site to 
produce the ?nal solution for application to the foliage as by 
spraying. LikeWise the herbicidal and the plant groWth 
regulant compositions of this invention include the more 
dilute aqueous solutions for use in application to the foliage. 
These more dilute aqueous solutions are preferably formed 
simply by suitably diluting a concentrate of this invention 
With Water (if a poWder or granular concentrate) or With 
more Water (if a liquid concentrate) to achieve the appro 
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priate dosage, but alternatively, can be formed on site by 
mixing the ingredients separately and/or in sub 
combinations With sufficient Water on site to achieve the 
appropriate dosage. Use of the solid or liquid concentrates of 
this invention is preferable as it is a much simpler operation 
and minimiZes the possibility of blending errors. Moreover, 
if desired, other components can be introduced into the ?nal 
solution at the time the concentrate is blended With Water to 
form the diluted solution for application to the foliage. 
The herbicides of the invention may be applied With a 
surfactant in order to improve leaf Wetting and assist in 
penetration of the active ingredient into the leaf. The sur 
factant is typically an inert ingredient in the formulation. 
Surfactants of virtually any class may be used. Examples of 
surfactants Which may be useful include StilWet, TWeen, 
polyalkylene glycols (such as polyethylene glycols), 
alkanolamides, betaine derivatives, ethoxylated propoxy 
lated block copolymers, glycerol esters, glycol esters, imi 
daZo1ines and imidaZoline derivatives, lanolin derivatives, 
lecithin derivatives, tertiary or quaternary polyoxyalkylene 
alkylamines, polyoxyalkylene and non-polyoxyalkylene 
alkylamine oxides, polyoxyalkylene alkylethers, polyoxy 
alkylene alkylarylethers, polyoxyalkylene alkylesters, 
alkoxylated and non-alkoxylated sorbitan esters, alkyl 
glycosides, alkyl polyglycosides, sucrose esters, sucrose 
glycerides, alkyl sulfates or phosphates, ole?n sulfonates, 
alkylaryl sulfonates, polyoxyalkylene alkylether sulfates or 
phosphates, sulfosuccinate derivatives, sulfosuccinamates, 
taurates, sulfates and sulfonates of oils, fatty acids, alcohols, 
alkoxylated alcohols, fatty esters and aromatic derivatives, 
mixtures thereof and the like. The surfactant is preferably 
StilWet. Those skilled in the art Will recogniZe that other 
surfactants not included above may also useful. 
Effective concentrations of the herbicides and herbicidal 
compositions and formulations of the invention may be 
readily determined using the methods described herein 
Wherein preparations are bioassayed for their inhibitory 
ability to knoWn preparations of peptide deformylase. In 
order to control groWth of vegetation, the compositions 
should contain the amount of inhibitor required to effectuate 
plant groWth regulant activity Whereby the further groWth of 
the vegetation is stunted, inhibited and/or s1oWed Without 
actually killing all of the undesired vegetation treated With 
the composition. 
Antagonists 
Peptide deformylase polypeptides of the invention may be 
used to assess the binding of small molecule substrates and 
ligands in, for example, cells, cell-free preparations, chemi 
cal libraries, and natural product mixtures. These substrates 
and ligands may be natural substrates and ligands or may be 
structural or functional mimetics. See, e.g., Coligan et al., 
Current Protocols in Immunology 1(2): Chapter 5 (1991). 
Accordingly, the invention provides a method of screen 
ing compounds to identify those Which block (antagonist) 
the action of peptide deformylase polypeptides. The method 
of screening may involve high-throughput techniques. For 
example, to screen for antagonists, a synthetic reaction mix, 
a cellular compartment, such as a membrane, cell envelope 
or cell Wall, or a preparation of any thereof, comprising a 
peptide deformylase polypeptide and a labeled substrate or 
ligand of such polypeptide is incubated in the absence or the 
presence of a candidate molecule that may be a peptide 
deformylase antagonist. The ability of the candidate mol 
ecule to antagoniZe the peptide deformylase polypeptide is 
re?ected in decreased binding of the labeled ligand or 
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decreased production of product from such substrate. Mol 
ecules that bind gratuitously, i.e., Without inducing the 
effects of a peptide deformylase polypeptide are most likely 
to be good antagonists. Detection of the rate or level of 
production of product from substrate may be enhanced by 
using a reporter system. Reporter systems that may be useful 
in this regard include but are not limited to colorimetric 
labeled substrate converted into product, a reporter gene that 
is responsive to changes in peptide deformylase polynucle 
otide or polypeptide activity, and binding assays knoWn in 
the art. 
Another example of an assay for peptide deformylase 
antagonists is a competitive assay that combines peptide 
deformylase and a potential antagonist With peptide 
deformylase-binding molecules, recombinant peptide 
deformylase binding molecules, natural substrates or 
ligands, or substrate or ligand mimetics, under appropriate 
conditions for a competitive inhibition assay. Peptide 
deformylase can be labeled, such as by radioactivity or a 
colorimetric compound, such that the number of peptide 
deformylase molecules bound to a binding molecule or 
converted to product can be determined accurately to assess 
the effectiveness of the potential antagonist. 
Potential antagonists include small organic molecules, 
peptides, polypeptides and antibodies that bind to a poly 
nucleotide or polypeptide of the invention and thereby 
inhibit or extinguish its activity. Potential antagonists also 
may be small organic molecules, a peptide, a polypeptide 
such as a closely related protein or antibody that binds the 
same sites on a binding molecule, such as a binding 
molecule, Without inducing peptide deformylase-induced 
activities, thereby preventing the action of peptide deformy 
lase by excluding deformylase from binding. 
Potential antagonists also include a small molecule that 
binds to and occupies the binding site of the polypeptide 
thereby preventing binding to cellular binding molecules, 
such that normal biological activity is prevented. Examples 
of small molecules include but are not limited to small 
organic molecules, peptides or peptide-like molecules. 
Other potential antagonists include antisense molecules (see 
Okano, J. Neurochem. 561560 (1991); Oligodeoxynucle 
otides as Antisense Inhibitors of Gene Expression, CRC 
Press, Boca Raton, Fla. (1988), for a description of these 
molecules). Preferred potential antagonists include com 
pounds related to and variants of peptide deformylase. 
Antibodies 
The present invention further relates to an antibody 
directed against plant peptide deformylase. In this regard, 
the polypeptides of the invention or variants thereof, or cells 
expressing them can be used as an antigen to produce 
antibodies immunospeci?c for such polypeptides. “Antibod 
ies” as used herein includes monoclonal and polyclonal 
antibodies, chimeric, single chain, simianiZed antibodies and 
humaniZed antibodies, as Well as Fab fragments, including 
the products of an Fab immunoglobulin expression library. 
Antibodies generated against the polypeptides of the 
invention can be obtained by administering the polypeptides 
or epitope-bearing fragments, analogues or cells to an ani 
mal using routine protocols. For preparation of monoclonal 
antibodies, any technique knoWn in the art that provides 
antibodies produced by continuous cell line cultures can be 
used. Examples include various techniques, such as those in 
Kohler, G. and Milstein, C., Nature 2561495—497 (1975); 
KoZbor et al., Immunology Today 4172 (1983); Cole et al., 
Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, 
Inc., pg.77—96 (1985). 
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Techniques for the production of single chain antibodies 
(US. Pat. No. 4,946,778) can be adapted to produce single 
chain antibodies to polypeptides of this invention. 
Alternatively phage display technology may be utiliZed to 
select antibody genes With binding activities toWards the 
polypeptide either from repertoires of PCR ampli?ed 
v-genes of lymphocytes from humans screened for possess 
ing anti-def or from naive libraries (McCafferty, J. et al., 
Nature 3481552—554 (1990); Marks, J. et al., Biotechnology 
101779—783 (1992)). The af?nity of these antibodies can also 
be improved by chain shuf?ing (Clackson, T. et al., Nature 
3521624—628 (1991)). 
If tWo antigen binding domains are present each domain 
may be directed against a different epitope—termed ‘bispe 
ci?c’ antibodies. 
The above-described antibodies may be employed to 
isolate or to identify clones expressing plant peptide 
deformylase polypeptides and to purify the polypeptides by 
af?nity chromatography. 
Transgenics 
As With other broad spectrum herbicides, such as 
glyphosate, overexpression or expression of altered forms of 
peptide deformylase in plants using conventional transfor 
mation techniques might generate plants resistant to the 
adverse effects of peptide deformylase inhibitors. 
Thus, the invention further relates to a transgenic plant, 
Wherein said plant is engineered to be resistant to inhibitors 
of plant peptide deformylase. In a further aspect, the present 
invention relates to a recombinant or transgenic plant trans 
formed With a peptide deformylase gene such that the 
deformylase is over expressed. 
Additionally, sense and antisense forms of the 
Arabidopsis, as Well as bacterial peptide deformylases, may 
be engineered into plant transformation vectors for the 
construction of transgenic plants With up- and doWn 
regulated levels of peptide deformylase, for testing as resis 
tant and susceptible plant species to peptide deformylase 
inhibitors. 
A variety of techniques may be used to introduce foreign 
genes into plant cells. One common method used to intro 
duce foreign genes into plant cells is transformation With 
disarmed Agrobacterium, a relatively benign natural plant 
pathogen. Agrobacterium actively mediates transformation 
events—the integration of a gene providing a desired phe 
notypic trait—as part of the natural process it utiliZes When 
it infects a plant cell. Methods for transferring foreign genes 
into plant cells and the subsequent expression of the inserted 
genes in plants regenerated from transformed cells are Well 
knoWn in the art. (See, e.g., De Block et al., The EMBO 
Journal 311681 (1984); Horsch et al. Science 22711229 
(1985); and C. L. Kado (Crit. Rev. Plant. Sci. 1011 (1991)). 
The technique knoWn as microprojectile bombardment 
has been successfully used to introduce genes encoding neW 
genetic traits into a number of crop plants, including cotton, 
maiZe, tobacco, sun?oWers, soybeans and certain veg 
etables. (See for example, US. Pat. No. 4,945,050, issued to 
Sanford; Sanford et al., Trends in Biotechnology 61299 
(1988); Sanford et al., Part. Sci. Technol. 5127 (1988); J. J. 
Finer and M. D. McMullen, Plant Cell Reports 81586—589 
(1990); and Gordon-Kamm, The Plant Cell 21603 (1990)). 
Organogenesis, the development of plantlets from speci?c 
plant structures such as leaf disks or root tips, has been used 
to regenerate plants folloWing transformation. An alternative 
approach has been described by Feldman, Who has shoWn 
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that it is feasible to vacuum in?ltrate the ?oral meristems of 
small plants, or in the case of Arabidopsis, the entire plant 
With Agrobacterium and obtain transgenic progeny. See K. 
A. Feldman et al.,“Agrobacterium-Mediated Transformation 
of Germinating Seeds of Arabidopsis thaliana: A Non 
Tissue Culture Approach,” Mol. Gen. Genet. 308:1—9 
(1987). 
The use of speci?c herbicides relies on differential uptake 
and/or metabolism betWeen Weed and crop plant or on 
application of the herbicide before planting in a ?eld. 
Herbicide tolerant plants/crops can be created by either of 
three strategies: i) increasing the level of the target enZyme 
for the herbicide (See, eg US. Pat. No. 4,940,835, issued 
to Shah et al.), ii) expressing a mutant enZyme that is not 
affected by the compound (Comai, L., et al., Nature 
317:741—744 (1985)), iii) expressing an enZyme that detoxi 
?es the herbicide (De Block, M., et al., EMBO J. 
6:2513—2518 (1987), Stalker, D. M., et al., Science 
242:419—423 (1988)), or iv) knocking out or antisense doWn 
regulation of the plant formyl transferase gene. 
With the ?rst approach, i), a cDNAencoding plant peptide 
deformylase may be transferred into a plant in order to over 
express the deformylase enZyme. Over expression of the 
enZyme alloWs the transgenic plants to groW in the presence 
of higher levels of the herbicide that kills the Wild-type or 
non-transgenic plants. 
With approach ii), herbicide-tolerant plants are created by 
use of mutant forms of the plant or bacterial peptide 
deformylase that are less sensitive to inhibition by the 
herbicide. Genes encoding these mutants may be cloned and 
expressed in plants. The transgenic plants should exhibit 
tolerance to levels of herbicide that kill Wild-type plants. 
Plant peptide deformylase is synthesiZed in the cytoplasm 
and translocated to the chloroplast by proteins that recogniZe 
and bind the amino-terminal region (transit peptide). In 
order to target the bacterial peptide deformylase to 
chloroplasts, a gene segment encoding the plant transit 
peptide may be fused to the coding sequence for the bacterial 
enzyme. 
The third approach for creating herbicide-tolerant plants 
employs transgenic expression of enZymes that convert the 
herbicide to a form that is not toxic to the plant. Some plants 
have their oWn detoxifying systems for certain herbicides. 
Some bacteria have been found that naturally degrade her 
bicides. 
The fourth approach for creating herbicide tolerant plants 
draWs from bacterial systems Where knock-out of the formyl 
transferase gene, Which codes for the formyl transferase 
enZyme responsible for the formation of 
N-formylmethionine, results in the formation of a cell line 
that While sloW in groWth, is no longer susceptible to peptide 
deformylase inhibitors or mutations in the peptide deformy 
lase gene. 
In order to express all or an effective part of the DNA 
sequence encoding a peptide deformylase protein of this 
invention in E. coli and in plants, suitable restriction sites 
can be introduced, ?anking the DNA sequence. This can be 
accomplished by site-directed mutagenesis, using Well 
knoWn procedures (Stanssens et al., Nucleic Acids Research 
12:4441—4454 (1989); White et al., Trends in Genet. 
5:185—189 (1989)). In order to obtain improved expression 
in plants, the codon usage of the peptide deformylase gene 
or effective peptide deformylase gene part of this invention 
can be modi?ed to form an equivalent, modi?ed or arti?cial 
gene or gene part, or gene parts can be inserted in the 
chloroplast genome and expressed there using a chloroplast 
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active promoter (e.g., McBride et al., Bio/Technology 
131362 (1995)). For obtaining enhanced expression in 
monocot plants such as corn, a monocot intron also can be 
added to the chimeric gene, and the DNA sequence of the 
peptide deformylase gene or part thereof can be further 
changed in a translationally neutral manner, to modify 
possibly inhibitory DNA sequences present in the gene or 
gene part by means of site-directed intron insertion and/or 
by introducing changes to the codon usage, e. g., adapting the 
codon usage to that most preferred by the speci?c plant 
(Murray et al., Nucleic Acids Research 17(2):477—498 
(1989)) Without changing signi?cantly the encoded amino 
acid sequence. 
Furthermore, the binding properties of the peptide 
deformylase proteins of the invention can be evaluated, 
using methods knoWn in the art. 
The peptide deformylase gene part or its equivalent, 
preferably a peptide deformylase chimeric gene, encoding a 
variant of the peptide deformylase, can be stably inserted in 
a conventional manner into the nuclear genome of a single 
plant cell, and the transformed plant cell can be used in a 
conventional manner to produce a transformed plant that is 
resistant to a peptide deformylase inhibitor. 
In this regard, a disarmed Ti-plasmid, containing the 
peptide deformylase gene or part thereof, in Agrobacterium 
tumefaciens can be used to transform the plant cell, and 
thereafter, a transformed plant can be regenerated from the 
transformed plant cell using the procedures described. For 
example, preferred Ti-plasmid vectors each contain the 
peptide deformylase gene or part thereof betWeen the border 
sequences, or at least located to the left of the right border 
sequence, of the T-DNA of the Ti-plasmid. Of course, other 
types of vectors can be used to transform the plant cell, using 
procedures such as direct gene transfer, pollen-mediated 
transformation, plant RNA virus-mediated transformation, 
liposome-mediated transformation, and other methods such 
as the recently described methods for transforming certain 
lines of corn (Fromm et al., Bio/Technology 8:833—839 
(1990); Gordon-Kamm et al., The Plant Cell 2:603—618 
(1990)) and rice (Shimamoto et al., Nature 338:274—276 
(1989); Datta et al., Bio/Technology 8:736—740 (1990)) and 
the recently described method for transforming monocots 
generally (PCT publication WO 92/09696). 
The resulting transformed plant can be used in a conven 
tional plant breeding scheme to produce more transformed 
plants With the same characteristics or to introduce the 
peptide deformylase gene part in other varieties of the same 
or related plant species. Seeds, Which are obtained from the 
transformed plants, contain the peptide deformylase gene 
part as a stable genomic insert. Cells of the transformed 
plant can be cultured in a conventional manner to produce 
the peptide deformylase protein Which can be recovered for 
use in methods of identifying herbicidal compounds. 
The peptide deformylase gene or gene part, preferably the 
truncated peptide deformylase gene, may be inserted in a 
plant cell genome so that the inserted gene is doWnstream 
(i.e., 3‘) of, and under the control of, a promoter Which can 
direct the expression of the gene part in the plant cell. This 
is preferably accomplished by inserting the peptide 
deformylase chimeric gene in the plant cell genome, par 
ticularly in the nuclear genome. Preferred promoters 
include: the strong constitutive 35S promoters (the “35S 
promoters”) of the cauli?oWer mosaic virus (CaMV) of 
isolates CM 1841 (Gardner et al., Nucleic Acids Research 
9:2871—2887 (1981)), CabbB-S (Franck et al., Cell 
21:285—294 (1980)) and CabbB-J1 (Hull and HoWell, Virol 
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ogy 86:482—493 (1987)); promoters from the ubiquitin fam 
ily (e.g., the maize ubiquitin promoter of Christensen et al., 
Plant Mol. Biol. 18:675—689 (1992), see also Cornejo et al., 
Plant Mol. Biol. 23:567—581 (1993)), the gos2 promoter (de 
Pater et al., 1992), the emu promoter (Last et al., Theor. 
Appl. Genet. 81:581—588 (1990)), rice actin promoters such 
as the promoter described by Zhang et al., The Plant Cell 
3:1155—1165 (1991); and the TR1‘ promoter and the TR2‘ 
promoter (the “TR1‘ promoter” and the “TR2‘ promoter”, 
respectively) Which drive the expression of the 1‘ and 2‘ 
genes, respectively, of the T-DNA (Velten et al., EMBO J. 
3:2723—2730 (1984)). 
Alternatively, a promoter can be utiliZed Which is not 
constitutive but rather is speci?c for one or more tissues or 
organs of the plant (e.g., leaves and/or roots) Whereby the 
inserted peptide deformylase gene part is expressed only in 
cells of the speci?c tissue(s) or organ(s). For example, the 
peptide deformylase gene part could be selectively 
expressed in the leaves of a plant (e.g., corn, cotton) by 
placing the gene part under the control of a light-inducible 
promoter such as the promoter of the ribulose-1,5 
bisphosphate carboxylase small subunit gene of the plant 
itself or of another plant such as pea as disclosed in US. Pat. 
No. 5,254,799. Another alternative is to use a promoter 
Whose expression is inducible (e.g., by temperature or 
chemical factors). 
The peptide deformylase gene or part thereof may be 
inserted in the plant genome so that the inserted gene part is 
upstream (i.e., 5‘) of suitable 3‘ end transcription regulation 
signals (i.e., transcript formation and polyadenylation 
signals). This is preferably accomplished by inserting the 
peptide deformylase chimeric gene in the plant cell genome. 
Preferred polyadenylation and transcript formation signals 
include those of the octopine synthase gene (Gielen et al., 
EMBO J. 3:835—845 (1984)) and the T-DNA gene 7 (Velten 
and Schell, Nucleic Acids Research 13:6981—6998 (1985)), 
Which act as 3‘-untranslated DNA sequences in transformed 
plant cells. 
The peptide deformylase gene or part thereof can option 
ally be inserted in the plant genome as a hybrid gene (US. 
Pat. No. 5,254,799; Vaeck et al., J. Econ. Entomol 55:140 
(1962)) under the control of the same promoter as a select 
able marker gene, such as the neo gene (EP 0 242 236) 
encoding kanamycin resistance, so that the plant expresses 
a fusion protein. 
GLOSSARY 
The folloWing de?nitions are provided to facilitate under 
standing of certain terms used frequently herein. 
A “host cell” is a cell Which has been transformed or 
transfected, or is capable of transformation or transfection 
by an exogenous polynucleotide sequence. 
“Homologous” or “substantial identity,” When referring to 
nucleic acids as used herein denotes a characteristic of a 
nucleic acid sequence, Wherein a nucleic acid sequence has 
at least about 70 percent sequence identity as compared to a 
reference sequence, typically at least about 85 percent 
sequence identity, and preferably at least about 95 percent 
sequence identity as compared to a reference sequence. The 
percentage of sequence identity is calculated excluding 
small deletions or additions Which total less than 25 percent 
of the reference sequence. “Identity,” as knoWn in the art, is 
a relationship betWeen tWo or more polypeptide sequences 
or tWo or more polynucleotide sequences, as determined by 
comparing the sequences. In the art, “identity” also means 
the degree of sequence relatedness betWeen polypeptide or 
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polynucleotide sequences, as the case may be, as determined 
by the match betWeen strings of such sequences. “Identity” 
and “similarity” can be readily calculated by knoWn 
methods, including but not limited to those described in 
(Computational Molecular Biology, Lesk, A. M., ed., 
Oxford University Press, NeW York, 1988; Biocomputing: 
Informatics and Genome Projects, Smith, D. W., ed., Aca 
demic Press, NeW York, 1993; Computer Analysis of 
Sequence Data, Part I, Grif?n, A. M., and Grif?n, H. G., eds., 
Humana Press, NeW Jersey, 1994; Sequence Analysis in 
Molecular Biology, von Heinje, G., Academic Press, 1987; 
and Sequence Analysis Primer, Gribskov, M. and Devereux, 
J., eds., M Stockton Press, NeW York, 1991; and Carillo, H., 
and Lipman, D., SIAM J. Applied Math., 48: 1073 (1988). 
Preferred methods to determine identity are designed to give 
the largest match betWeen the sequences tested. Methods to 
determine identity and similarity are codi?ed in publicly 
available computer programs. Preferred computer program 
methods to determine identity and similarity betWeen tWo 
sequences include, but are not limited to, the GCG program 
package (Devereux, J ., et al., Nucleic Acids Research 12(1): 
387 (1984)), BLASTP, BLASTN, and FASTA (Atschul, S. F. 
et al., J. Molec. Biol. 215: 403—410 (1990). The BLAST X 
program is publicly available from NCBI and other sources 
(BLAST Manual, Altschul, S., et al., NCBI NLM NIH 
Bethesda, Md. 20894; Altschul, S., et al., J. Mol. Biol. 215: 
403—410 (1990). As an illustration, by a polynucleotide 
having a nucleotide sequence having at least, for example, 
95% “identity” to a reference nucleotide sequence, it is 
intended that the nucleotide sequence of the polynucleotide 
is identical to the reference sequence except that the poly 
nucleotide sequence may include up to ?ve point mutations 
per each 100 nucleotides of the reference nucleotide 
sequence. In other Words, to obtain a polynucleotide having 
a nucleotide sequence at least 95% identical to a reference 
nucleotide sequence, up to 5% of the nucleotides in the 
reference sequence may be deleted or substituted With 
another nucleotide, or a number of nucleotides up to 5% of 
the total nucleotides in the reference sequence may be 
inserted into the reference sequence. These mutations of the 
reference sequence may occur at the 5‘ or 3‘ terminal 
positions of the reference nucleotide sequence or anyWhere 
betWeen those terminal positions, interspersed either indi 
vidually among nucleotides in the reference sequence or in 
one or more contiguous groups Within the reference 
sequence. Analogously, by a polypeptide having an amino 
acid sequence having at least, for example, 95% identity to 
a reference amino acid sequence, it is intended that the 
amino acid sequence of the polypeptide is identical to the 
reference sequence except that the polypeptide sequence 
may include up to ?ve amino acid alterations per each 100 
amino acids of the reference amino acid. In other Words, to 
obtain a polypeptide having an amino acid sequence at least 
95% identical to a reference amino acid sequence, up to 5% 
of the amino acid residues in the reference sequence may be 
deleted or substituted With another amino acid, or a number 
of amino acids up to 5% of the total amino acid residues in 
the reference sequence may be inserted into the reference 
sequence. These alterations of the reference sequence may 
occur at the amino or carboxy terminal positions of the 
reference amino acid sequence or anyWhere betWeen those 
terminal positions, interspersed either individually among 
residues in the reference sequence or in one or more con 
tiguous groups Within the reference sequence. The reference 
sequence in the instant case may be the sequence of Atdef1, 
Atdef2, AT DEF1, or AtDEF2. 
“Isolated” means altered “by the hand of man” from its 
natural state, i.e., if it occurs in nature, it has been changed 
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or removed from its original environment, or both. For 
example, a polynucleotide or a polypeptide naturally present 
in a living organism is not “isolated”, but the same poly 
nucleotide or polypeptide separated from the coexisting 
materials of its natural state is “isolated”, as the term is 
employed herein. 
“Polynucleotide(s)” generally refers to any polyribo 
nucleotide or polydeoxribonucleotide, Which may be 
unmodi?ed RNA or DNA or modi?ed RNA or DNA. 
“Polynucleotide(s)” include, Without limitation, single- and 
double-stranded DNA, DNA that is a mixture of single- and 
double-stranded regions or single-, double- and triple 
stranded regions, single- and double-stranded RNA, and 
RNA that is mixture of single- and double-stranded regions, 
hybrid molecules comprising DNA and RNA that may be 
single-stranded or, more typically, double-stranded, or 
triple-stranded regions, or a mixture of single- and double 
stranded regions. In addition, “polynucleotide” as used 
herein refers to triple-stranded regions comprising RNA or 
DNA or both RNA and DNA. The strands in such regions 
may be from the same molecule or from different molecules. 
The regions may include all of one or more of the molecules, 
but more typically involve only a region of some of the 
molecules. One of the molecules of a triple-helical region 
often is an oligonucleotide. As used herein, the term 
“polynucleotide(s)” also includes DNAs or RNAs as 
described above that contain one or more modi?ed bases. 
Thus, DNAs or RNAs With backbones modi?ed for stability 
or for other reasons are “polynucleotide(s)” as that term is 
intended herein. Moreover, DNAs or RNAs comprising 
unusual bases, such as inosine, or modi?ed bases, such as 
tritylated bases, to name just tWo examples, are polynucle 
otides as the term is used herein. It Will be appreciated that 
a great variety of modi?cations have been made to DNA and 
RNA that serve many useful purposes knoWn to those of 
skill in the art. The term “polynucleotide(s)” as it is 
employed herein embraces such chemically, enZymatically 
or metabolically modi?ed forms of polynucleotides, as Well 
as the chemical forms of DNA and RNA characteristic of 
viruses and cells, including, for example, simple and com 
plex cells. “Polynucleotide(s)” also embraces short poly 
nucleotides often referred to as oligonucleotide(s). 
“Polypeptide(s)” refers to any peptide or protein compris 
ing tWo or more amino acids joined to each other by peptide 
bonds or modi?ed peptide bonds. “Polypeptide(s)” refers to 
both short chains, commonly referred to as peptides, oli 
gopeptides and oligomers and to longer chains generally 
referred to as proteins. Polypeptides may contain amino 
acids other than the 20 gene encoded amino acids. 
“Polypeptide(s)” include those modi?ed either by natural 
processes, such as processing and other post-translational 
modi?cations, but also by chemical modi?cation techniques. 
Such modi?cations are Well described in basic texts and in 
more detailed monographs, as Well as in a voluminous 
research literature, and they are Well knoWn to those of skill 
in the art. It Will be appreciated that the same type of 
modi?cation may be present in the same or varying degree 
at several sites in a given polypeptide. Also, a given 
polypeptide may contain many types of modi?cations. 
Modi?cations can occur anyWhere in a polypeptide, includ 
ing the peptide backbone, the amino acid side-chains, and 
the amino or carboxyl termini. 
Modi?cations include, for example, acetylation, 
acylation, ADP-ribosylation, amidation, covalent attach 
ment of ?avin, covalent attachment of a heme moiety, 
covalent attachment of a nucleotide or nucleotide derivative, 
covalent attachment of a lipid or lipid derivative, covalent 
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attachment of phosphotidylinositol, cross-linking, 
cycliZation, disul?de bond formation, demethylation, for 
mation of covalent cross-links, formation of cysteine, for 
mation of pyroglutamate, formylation, gamma 
carboxylation, glycosylation, GPI anchor formation, 
hydroxylation, iodination, methylation, myristoylation, 
oxidation, proteolytic processing, phosphorylation, 
prenylation, racemiZation, glycosylation, lipid attachment, 
sulfation, gamma-carboxylation of glutamic acid residues, 
hydroxylation and ADP-ribosylation, selenoylation, 
transfer-RNA mediated addition of amino acids to proteins, 
such as arginylation, and ubiquitination. (See, for example, 
Proteins-structure And Molecular Properties, 2nd Ed., T. E. 
Creighton, W. H. Freeman and Company, NeW York (1993) 
and Wold, F., Posttranslational Protein Modi?cation Per 
spectives and Prospects, pgs. 1—12 in Posttranslational 
Covalent Modi?cation of Proteins, B. C. Johnson, Ed., 
Academic Press, NeW York (1983); Selfer et al., Meth. 
EnZymol. 182:626—646E(1990) and Rattan et al., Protein 
Synthesis: Posttranslational Modi?cations and Aging, Ann. 
NY. Acad. Sci. 663:48—62 (1992)). Polypeptides may be 
branched or cyclic, With or Without branching. Cyclic, 
branched and branched circular polypeptides may result 
from post-translational natural processes and may be made 
by entirely synthetic methods, as Well. The terms “peptide”, 
“polypeptide” or “protein” are used interchangeably herein. 
“Stringent hybridiZation conditions” refers to conditions 
Which permit hybridiZation betWeen polynucleotides. Strin 
gent conditions can be de?ned by salt concentration, the 
concentration of organic solvent (e.g., formamide), 
temperature, and other conditions Well knoWn in the art. In 
particular, stringency can be increased by reducing the 
concentration of salt, increasing the concentration of 
formamide, or raising the hybridiZation temperature. For 
example, stringent salt concentration Will ordinarily be less 
than about 750 mM NaCl and 75 mM trisodium citrate, 
preferably less than about 500 mM NaCl and 50 mM 
trisodium citrate, and most preferably less than about 250 
mM NaCl and 25 mM trisodium citrate. LoW stringency 
hybridiZation can be obtained in the absence of organic 
solvent, e.g., formamide, While high stringency hybridiZa 
tion can be obtained in the presence of at least about 35% 
formamide, and most preferably at least about 50% forma 
mide. Stringent temperature conditions Will ordinarily 
include temperatures of at least about 30° C., more prefer 
ably of at least about 37° C. and most preferably of at least 
about 42° C. Varying additional parameters, such as hybrid 
iZation time, the concentration of detergent, e.g., sodium 
dodecyl sulfate (SDS), and the inclusion or exclusion of 
carrier DNA, are Well knoWn to those skilled in the art. 
Various levels of stringency are accomplished by combining 
these various conditions as needed. The Washing steps Which 
folloW hybridiZation can also vary in stringency. Wash 
stringency conditions can be de?ned by salt concentration 
and by temperature. As above, Wash stringency can be 
increased by decreasing salt concentration or by increasing 
temperature. For example, stringent salt concentration for 
the Wash steps Will preferably be less than about 30 mM 
NaCl and 3 mM trisodium citrate, and most preferably less 
than about 15 mM NaCl and 1.5 mM trisodium citrate. 
Stringent temperature conditions for the Wash steps Will 
ordinarily include temperature of at least about 25° C., more 
preferably of at least about 42° C., and most preferably of at 
least about 68° C. Will occur at 42° C. in 15 mM NaCl, 1.5 
mM trisodium citrate, and 0.1% SDS. Additional variations 
on these conditions Will be readily apparent to those skilled 
in the art. 
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“Variant(s)” as the term is used herein, is a polynucleotide 
or polypeptide that differs from a reference polynucleotide 
or polypeptide respectively, but retains essential properties. 
A typical variant of a polynucleotide differs in nucleotide 
sequence from another reference polynucleotide. Changes in 
the nucleotide sequence of the variant may or may not alter 
the amino acid sequence of a polypeptide encoded by the 
reference polynucleotide. Nucleotide changes may result in 
amino acid substitutions, additions, deletions, fusions and 
truncations in the polypeptide encoded by the reference 
sequence, as discussed beloW. Atypical variant of a polypep 
tide differs in amino acid sequence from another, reference 
polypeptide. Generally, differences are limited so that the 
sequences of the reference polypeptide and the variant are 
closely similar overall and, in many regions, identical. A 
variant and reference polypeptide may differ in amino acid 
sequence by one or more substitutions, additions, deletions 
in any combination. A substituted or inserted amino acid 
residue may or may not be one encoded by the genetic code. 
A variant of a polynucleotide or polypeptide may be a 
naturally occurring such as an allelic variant, or it may be a 
variant that is not knoWn to occur naturally. Non-naturally 
occurring variants of polynucleotides and polypeptides may 
be made by mutagenesis techniques, by direct synthesis, and 
by other recombinant methods knoWn to skilled artisans. 
All references cited in the present application are 
expressly incorporated by reference herein. 
The folloWing examples are provided for illustrative 
purposes and are not intended to limit the scope of the 
invention as claimed herein. Any variations in the exempli 
?ed compositions and methods that occur to the skilled 
artisan are intended to fall Within the scope of the present 
invention. 
EXAMPLE 1 
Identi?cation and Isolation of an Arabidopsis 
Peptide Deformylase Gene (Atdef1) 
The Arabidopsis thaliana genome sequencing project 
recently annotated a gene (AC007591; F9L1.35 
@http:WWW.ncbi.nlm.nih.gov;) as a putative peptide 
deformylase based on substantial homology to Chlamydia 
pneumoniae (AE001687) protein. An identi?able chloro 
plast targeting sequence Was also identi?ed. The predicted 
protein sequence Was analyZed using the ChloroP program 
(Emanuelsson et al., Protein Science 8:978—984 (1999)), 
Which revealed a putative transit peptide of 50 amino acids. 
(See FIGS. 1A and 1B.) 
Construction of a Peptide Deformylase Clone (Atdef1) 
Experiments Were initiated to amplify Arabidopsis 
thaliana peptide deformylase complementary DNA (cDNA) 
using Reverse Transcriptase-Polymerase Chain Reaction 
(RT-PCR). 
Isolation of Arabidopsis thaliana RNA 
Total RNA Was isolated using TRIZolTM reagent from 
GIBCO BRL, folloWing the manufacturer’s protocol. 
Brie?y, the procedure Was as folloWs: 0.5 gm Arabidopsis 
thaliana cv. Columbia leaves Were homogeniZed in 5 ml of 
TRIZolTM reagent With a Polytron homogeniZer for 10—15 
seconds using a poWer setting of 5. FolloWing a 5 minute 
room temperature incubation, 1.0 ml of chloroform Was 
added. The samples Were mixed and centrifuged at 12,000><g 
for 15 minutes at 4° C. FolloWing centrifugation, the aque 
ous phase Was removed and the RNA precipitated With 2.5 
ml of isopropyl alcohol. The precipitate Was collected by 
centrifugation at 12,000><g for 10 minutes at 4° C. The RNA 
pellet Was Washed With 1.0 ml of 70% ethanol, dried brie?y, 
and resuspended in DEPC-treated Water. 
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First Strand cDNA Synthesis 
First strand cDNA Was prepared from RNA isolated from 
Arabidopsis thaliana cells using gene speci?c primers RLH 
146 (SEQ ID NO.: 1) and 147 (SEQ ID NO.: 2) having the 
sequence 5‘ TTG TCG ACAAAA GCC GGT TGG 3‘ and 5‘ 
TCA TTG AGG TCC GAG CTT AG 3‘, respectively. The 
reverse transcription reaction Was carried out in a 20 pl 
reaction volume containing 4 pl of RNA (150 ng/ml), 1.5 pl 
of 3‘ antisense oligo (likely RLH 147) (10 pM stock diluted 
to a ?nal concentration of 0.75 pM), 8.5 pl of Water, 1 pl of 
20 mM each dATP, dGTP, dCTP, dTTP (?nal concentration 
of 1 mM), 2 pl of MgCl2 (to ?nal concentration of 5 mM), 
2 pl of PCR buffer (10x: 200 mM Tris-HCl, pH 8.4, 500 mM 
KCl) used according to the manufacturer’s instructions 
(Gibco BRL® Life TechnologiesTM) and 200 units of 
MMLV reverse transcriptase (Gibco BRL® Life 
TechnologiesTM) for 30 minutes at 42° C. in a RoboCycler® 
Gradient 40 Temperature Cycler (Stratagene®; La Jolla, 
Calif., USA 92037). This reaction Was terminated by incu 
bation at 99° C. for 5 minutes and subsequently cooled to 6° 
C. 
Polymerase Chain Reaction 
The ?rst strand cDNA Was used as a PCR template. 
RoboCycler® Gradient 40 Temperature Cycler Was used 
With the folloWing temperature regime: 
1 cycle 3 minutes 94° C. 
35 cycles 1 minute 94° C., 1 minute 50° C., 1 minute 72° C. 
1 cycle 10 minutes 72° C. 
The reaction product Was analyZed by adding an aliquot 
of the reaction mixture to loading dye and loading into Wells 
of a 1% TAE gel and subjecting the gel to electrophoresis. 
(FIG. 2.) 
Ligation to pCR®2.1 Vector 
The amplicon of the expected siZe, 630 bp, Was cloned 
into pCR®2.1 TA-vector (Invitrogen). (See FIG. 2.) The 10 
pl ligation reaction mixture contained 1—2 pl of PCR 
product, 1 pl of 10><ligation buffer, 2 pl of pCR®2.1 vector 
(25 ng/pl), sterile Water to a total volume of 10 pl. One 
microliter of T4 DNA Ligase (4.0 Weiss units) Was added to 
the reaction mixture and the ligation reaction Was incubated 
at 14° C. for a 14—16 hours. 
Transformation 
To each vial of One ShotTM INVotF‘ competent cells 
(Invitrogen) Were added 2 pl of 0.5 M [3-mercaptoethanol 
and the sample Was mixed by stirring gently With a pipette 
tip. AfterWards, 2 pl of the TA Cloning® reaction (ligation 
reaction) Were added into a vial of One ShotTM cells and 
mixed gently. The mixture Was incubated on ice for 30 
minutes. The cells Were subjected to heat shock for 30 
seconds at 42° C. Without shaking. The cells Were then 
immediately transferred to ice and incubated for 2 minutes. 
Next, 250 pl of room temperature SOC medium 
(formulation per liter: 20 g tryptone, 5 g yeast extract, 0.5 g 
NaCl, 0.95 g MgCl2, and 20 mM glucose) Were added. The 
tube Was capped tightly and shaken horiZontally at 37° C. for 
60 minutes. 
Approximately, 50—100 pl from each transformation Were 
spread on a preWarmed LB-agar plate containing the 100 
pig/ml ampicillin and X-Gal, and the inverted plates Were 
incubated overnight at 37° C. Approximately 10 White or 
light blue colonies Were picked for analysis. 
Sequence Analysis 
Determination of the DNA sequence of the insert con 
?rmed that this plasmid had the expected and desired 









